期刊文献+

分子佐剂在DNA疫苗中的应用 被引量:1

The Application of Molecular Adjuvant in DNA Vaccine
下载PDF
导出
摘要 如何增强和提高DNA疫苗的免疫效果是新一代DNA疫苗分子设计和研究的关键问题,其中之一就是应用分子佐剂来优化DNA疫苗。分子佐剂可将以基因方式传递的免疫刺激分子与DNA疫苗共免疫,在体内表达相应的蛋白,增强T、B细胞对疫苗成分的体液及细胞免疫应答。目前研究较多的分子佐剂有:细胞因子如干扰素(IFN)、白细胞介素2(IL-2)、IL-12、粒细胞-巨噬细胞集落刺激因子(GM-CSF)等;共刺激分子如B7-2、CD40L等;补体佐剂如C3;免疫刺激序列如CpG、寡核苷酸(ODN)等。分子佐剂在体内与疫苗基因共表达,改善抗原的周边微环境,提高疫苗的免疫效果。因此,分子佐剂是目前DNA疫苗研究中的热点问题之一。 How to enhance and promote the immunological effects is the key point of the design and study of new DNA vaccine, and one strategy is the optimization of DNA vaccine using molecular adjuvant. The molecular adjuvant can make co-immune of DNA vaccine and immuno-stimulation molecular transferred by gene. The in vivo expressions of corresponding proteins can enhance the humoral and eellullar immunologic responses of T and B cells. At present, the molecular adjuvants have drawn more attentions especially the cytokines, such as interferon (IFN), interleukin (IL-2 and IL-12) and granulocyte-macrophage colony-stimulating factor (GM-CSF); co-stimulatory molecules, such as B7-2 and CD40L; complement adjuvant C3; imnmostimulation sequences, such as CpG and ODN. The molecular adjuvants, which co-expressed with vaccine genes in vivo, can improve the surrounding microenvironments and promote the immunological effects of vaccine. Therefore, molecular adjuvant is one of the present hot spots of DNA vaccine studies.
出处 《国际生殖健康/计划生育杂志》 CAS 2009年第3期205-208,共4页 Journal of International Reproductive Health/Family Planning
基金 国家自然科学基金(30571864) 第三军医大学青年基金资助
关键词 DNA疫苗 分子佐剂 细胞免疫 体液免疫 DNA vaccine Molecular adjuvant Cell immunity Humoral immunity
  • 相关文献

参考文献20

  • 1Tovey MG, Lallemand C, Thyphronitis G. Adjuvant activity of type Ⅰ interferans [J]. Biol Chem, 2008, 389(5): 541-545.
  • 2Bracci L, La Sorsa V, Belardelli F, et al. Type Ⅰ interferons as vaccine adjuvants against infectious diseases and cancer [J]. Expert Rev Vaccines, 2008, 7(3): 373-381.
  • 3Halwani R, Boyer JD, Yassine-Diab B, et al. Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL- 15 induces distinct CD8 memory subsets in SIV-infected macaques [J]. J Immunol, 2008, 180(12): 7969-7979.
  • 4Yo YT, Hsu KF, Shieh GS, et al. Coexpression of Fit3 ligand and GM-CSF genes modulates immune responses induced by HER2/ neu DNA vaccine [J]. Cancer Gene Ther, 2007, 14(11): 904-917.
  • 5Robinson TM, Sidhu MK, Pavlakis GN, et al. Macaques coimmunized with SIVgag/pol-HIVenv and IL-12 plasmid have increased cellular responses [ J ]. J Med Primatol, 2007, 36(4-5): 276- 284.
  • 6Westermann J, Nguyen-Hoai T, Baldenhofer G, et al. CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity [ J ]. Cancer Gene Ther, 2007, 14(6): 523-532.
  • 7Yamano T, Kaneda Y, Hiramatsu SH, et al. Immunity against breast cancer by TERT DNA vaccine primed with chemokine CCL21 [J]. Cancer Gene Ther, 2007, 14(5): 451-459.
  • 8Zhang X, Divangahi M, Ngai P, et al. Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene [J]. Vaccine, 2007, 25(7): 1342-1352.
  • 9Mealey RH, Stone DM, Hines MT, et al. Experimental Rhodococcus equi and equine infectious anemia virus DNA vaccination in adult and neonatal horses: effect of IL-12, dose, and route [J]. Vaccine, 2007, 25(43): 7582-7597.
  • 10Koch M, Frazier J, Sodroski J, et al. Characterization of antibody responses to purified HIV-1 gp120 glycoproteins fused with the molecular adjuvant C3d [J]. Virology, 2005, 340(2): 277-284.

同被引文献4

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部